RxDoctor Payments Data

Julie Bulman, MD

Vascular & Interventional Radiology · Boston, MANPI 1710320791

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Argon Medical Devices, Inc. accounts for 66.4% of it on its own, with 5 other manufacturers making up the rest.

$23,552in general payments, 2019–2025

Across 34 payments — averaging $692.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Argon Medical Devices, Inc.$16K
  • Endovascular Engineering Inc.$8K
  • Medtronic$322
  • Stryker$51
  • Baylis Medical Technologies Inc.$15
  • Cook Medical LLC$15

What the payments were for

  • Consulting fees$11,88250%
  • Speaking & faculty fees$9,13439%
  • Food & beverage$2,53611%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Argon Medical Devices, Inc.25$15,649
Endovascular Engineering Inc.2$7,500
Medtronic(2 entities)4$322
Stryker1$51
Baylis Medical Technologies Inc.1$15
Cook Medical LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,552 in reported general payments places this provider in the 85th percentile of 89 vascular & interventional radiology providers in Massachusetts.

See all vascular & interventional radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$49,771
Medicare patients
251
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →